Items by Cordery, Sarah
|Up a level|
Number of items: 7.
Bastos Leal, L., Cordery, S., Delgado-Charro, M., Bunge, A.L. and Guy, R., 2017. Forthcoming. Bioequivalence methodologies for topical drug products:in vitro and ex vivo studies with a cortiscosteroid and an anti-fungal drug. Pharmaceutical Research
Clarke, J. F., Cordery, S. F., Morgan, N. A., Knowles, P. K. and Guy, R. H., 2015. In vitro method to quantify dermal absorption of pesticide residues. Chemical Research in Toxicology, 28 (2), pp. 166-168.
Cordery, S. F., Taverner, A., Ridzwan, I. E., Guy, R. H., Delgado-Charro, M. B., Husbands, S. M. and Bailey, C. P., 2014. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm. Addiction Biology, 19 (4), pp. 575-586.
Belsey, N. A., Cordery, S. F., Bunge, A. L. and Guy, R. H., 2011. Assessment of dermal exposure to pesticide residues during re-entry. Environmental Science & Technology, 45 (10), pp. 4609-4615.
Yang, Q., Cordery, S. and Guy, R. H., 2010. Application of biophysics and bioengineering to the assessment of barrier function. Journal of Pharmacy and Pharmacology, 62 (10), pp. 1249-1250.
Cordery, S. F., 2015. Transdermal delivery of a buprenorphine/naltrexone combination for the treatment of polydrug abuse. Thesis (Doctor of Philosophy (PhD)).